METHOD FOR ENHANCING OPTIC NERVE ATROPHY TREATMENT EFFECTIVENESS IN CHILDREN Russian patent published in 2007 - IPC A61F9/00 A61N1/32 A61K31/194 A61K31/525 A61P27/02 

FIELD: medicine.

SUBSTANCE: method involves intravenously dripping Cytoflavin at a dose of 0.5 ml per 1 year of life. Cytoflavin is introduced during the first 2-3 days from transcutaneous electrostimulation onset in equalizing parabiosis phase and during the first 4-5 days in paradoxical phase and during the first 6-8 days in inhibitory phase. Current intensity of 15-200 mcA of frequency not exceeding 30 Hz is applied in performing the electrostimulation. An electrode is first set over nasal upper eyelid point and then, 30 s later, on temporal upper eyelid point. The total transcutaneous electrostimulation treatment course is 10 days long, giving four treatment series on the eyes every day.

EFFECT: improved vision function recovery; increased optic nerve conductivity.

1 tbl